Amanote Research

Amanote Research

    RegisterSign In

Solving Doubts About L-Ornithine L-Aspartate for Overt HE: Whom and How to Treat

Hepatology - United States
doi 10.1002/hep.29530
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHepatology
Date

January 1, 2018

Authors
Piero AmodioJavier Ampuero
Publisher

Wiley


Related search

L-Ornithine L-Aspartate in Bouts of Overt Hepatic Encephalopathy

Hepatology
MedicineHepatology
2017English

Reply: Terminating an Episode of Overt Hepatic Encephalopathy - L - Ornithine L-Aspartate May Have Some Role

Hepatology
MedicineHepatology
2018English

L-Ornithine-L-Aspartate in Experimental Portal-Systemic Encephalopathy: Therapeutic Efficacy and Mechanism of Action

Journal of Hepatology
Hepatology
1998English

Terminating an Episode of Overt Hepatic Encephalopathy- Lornithine L-Aspartate May Have Some Role

Hepatology
MedicineHepatology
2017English

Identification of Essential Active-Site Residues in Ornithine Decarboxylase of Nicotiana Glutinosa Decarboxylating Both L-Ornithine and L-Lysine

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2001English

Controversies and Consensus Regarding Vitamin D Deficiency in 2015: Whom to Test and Whom to Treat?

Medical Journal of Australia
Medicine
2015English

L-Ornithine Derived Polyamines in Cystic Fibrosis Airways

PLoS ONE
Multidisciplinary
2012English

Doubts About Quantal Analysis

Journal of Neurophysiology
NeurosciencePhysiology
2007English

How Much, for What, and for Whom?

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy